John Hornberger

4.1k total citations · 1 hit paper
42 papers, 2.8k citations indexed

About

John Hornberger is a scholar working on Economics and Econometrics, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, John Hornberger has authored 42 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Economics and Econometrics, 6 papers in Surgery and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in John Hornberger's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Economic and Financial Impacts of Cancer (3 papers) and Statistical Methods in Clinical Trials (3 papers). John Hornberger is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Economic and Financial Impacts of Cancer (3 papers) and Statistical Methods in Clinical Trials (3 papers). John Hornberger collaborates with scholars based in United States, Canada and United Kingdom. John Hornberger's co-authors include Milton C. Weinstein, Jeanne Jackson, Bryan R. Luce, Magnus Johannesson, Bernie J. OʼBrien, Chris McCabe, Leon E. Cosler, Gary H. Lyman, Jennie H. Best and David L. Veenstra and has published in prestigious journals such as JAMA, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

John Hornberger

41 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies

2003 883 citations Milton C. Weinstein, Bernie J. OʼBrien et al. Value in Health profile →

Peers

Countries citing papers authored by John Hornberger

Since Specialization

Citations

This map shows the geographic impact of John Hornberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Hornberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Hornberger more than expected).

Fields of papers citing papers by John Hornberger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Hornberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Hornberger. The network helps show where John Hornberger may publish in the future.

Co-authorship network of co-authors of John Hornberger

This figure shows the co-authorship network connecting the top 25 collaborators of John Hornberger. A scholar is included among the top collaborators of John Hornberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Hornberger. John Hornberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A Promising New Strategy to Improve Treatment Outcomes for Patients with Depression 2018 ·Population Health Management ·George Carpenter, Henry T. Harbin, Robin L. Smith, John Hornberger, David B. Nash	5
2	Cost-Effectiveness of Florbetapir-PET in Alzheimer's Disease: A Spanish Societal Perspective. 2015 ·PubMed ·John Hornberger, (unknown), (unknown), (unknown), Tatiana Dilla, Michael Happich	15
3	An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population 2015 ·PLoS ONE ·Peter Benn, Kirsten J. Curnow, (unknown), (unknown), John Hornberger, Matthew Rabinowitz	38
4	Clinical validity of cytochrome P450 metabolism and serotonin gene variants in psychiatric pharmacotherapy 2013 ·International Review of Psychiatry ·C. Anthony Altar, John Hornberger, Ashwini Shewade, (unknown), Jill Garrison, David A. Mrazek	69
5	Laboratory-Developed Test—SynFRAME: An Approach for Assessing Laboratory-Developed Tests Synthesized from Prior Appraisal Frameworks 2012 ·Genetic Testing and Molecular Biomarkers ·John Hornberger, Julie Doberne, (unknown)	14
6	Rechargeable Spinal Cord Stimulation Versus Nonrechargeable System for Patients With Failed Back Surgery Syndrome: A Cost-Consequences Analysis 2008 ·Clinical Journal of Pain ·John Hornberger, Krishna Kumar, (unknown), Mary Ann Clark, John Hernandez	56
7	Relationship Between Antiretroviral Prescribing Patterns and Treatment Guidelines in Treatment-Naive HIV-1-Infected US Veterans (1992-2004) 2006 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Mark Holodniy, John Hornberger, (unknown), (unknown), Thomas MaCurdy, (unknown), Paul A. Volberding, Lawrence Deyton	23
8	Cost-Effectiveness of Enfuvirtide in HIV Therapy for Treatment-Experienced Patients in the United States 2006 ·AIDS Research and Human Retroviruses ·John Hornberger, J Michael Kilby, Neil Wintfeld, Jesse Green	16
9	Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection 2006 ·Journal of Clinical Virology ·John Hornberger, Francesca J. Torriani, Douglas T. Dieterich, Norbert Bräu, Mark Sulkowski, (unknown), Jesse Green, Kavita Patel	20
10	The economics of treating chronic hepatitis C patients with peginterferon α‐2a (40 kDa) plus ribavirin presenting with persistently normal aminotransferase* 2006 ·Journal of Viral Hepatitis ·John Hornberger, Patrizia Farci, Daniele Prati, Stefan Zeuzem, (unknown), Kiran Klaus Patel	14
11	Randomized Trial of Folic Acid for Prevention of Cardiovascular Events in End-Stage Renal Disease 2004 ·Journal of the American Society of Nephrology ·Elizabeth M. Wrone, John Hornberger, James L. Zehnder, Linda McCann, Norman S. Coplon, Stephen P. Fortmann	178
12	Pharmacoeconomics of folic acid supplementation for cardiovascular disease prevention 2003 ·Expert Review of Pharmacoeconomics & Outcomes Research ·Elizabeth M. Wrone, John Hornberger	0
13	Principles of Good Practice for Decision Analytic Modeling in Health-Care Evaluation: Report of the ISPOR Task Force on Good Research Practices—Modeling Studies breakdown → 2003 ·Value in Health ·Milton C. Weinstein, Bernie J. OʼBrien, John Hornberger, Jeanne Jackson, Magnus Johannesson, Chris McCabe, Bryan R. Luce	883
14	Meta-analysis of subcutaneous versus intravenous epoetin in maintenance treatment of anemia in hemodialysis patients 2002 ·American Journal of Kidney Diseases ·Anatole Besarab, Carolina Reyes, John Hornberger	97
15	An MTHFR variant, homocysteine, and cardiovascular comorbidity in renal disease 2001 ·Kidney International ·Elizabeth M. Wrone, James L. Zehnder, John Hornberger, Linda McCann, Norman S. Coplon, Stephen P. Fortmann	70
16	INTRODUCTION TO BAYESIAN REASONING 2001 ·International Journal of Technology Assessment in Health Care ·John Hornberger	12
17	Patient preferences in coronary revascularization 1999 ·American Heart Journal ·John Hornberger, D. Blöch, Mark A. Hlatky, Wolf‐Dieter Baumgartner	12
18	Incidence and long-term cost of steroid-related side effects after renal transplantation 1999 ·American Journal of Kidney Diseases ·David L. Veenstra, Jennie H. Best, John Hornberger, Sean D. Sullivan, Donald E. Hricik	235
19	When To Base Clinical Policies on Observational Versus Randomized Trial Data 1997 ·Annals of Internal Medicine ·John Hornberger, (unknown)	54
20	The Effect of a Patient's Risk-Taking Attitude on the Cost Effectiveness of Testing Strategies in the Evaluation of Pulmonary Lesions 1997 ·CHEST Journal ·Stephen S. Raab, John Hornberger	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact